Methyl Alcohol

Methyl Alcohol

SCHEMBL9949464

CC1=CC2CCC1C2.CO

nearest known ligand 0.32

Full drug profile on Sugi Atlas →

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6715260 0.95
SCHEMBL165725 0.95
Hydrogen Sulfide SCHEMBL15656552 0.93
Bicarbonate SCHEMBL997094 0.89 CYP19A1 (0.36) CYP19A1
SCHEMBL1416850 0.85
SCHEMBL4462982 0.82 CYP19A1 (0.35) CYP19A1
SCHEMBL2010694 0.79
SCHEMBL17200865 0.76 ALDH1A1 (0.46) CYP19A1
SCHEMBL220699 0.70
SCHEMBL9625106 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9440939-B2 Norbornene derivative JNC CORPORATION (JP) 2016-09-13 US disclosed
US-20150307467-A1 NOVEL NORBORNENE DERIVATIVE JNC PETROCHEMICAL CORPORATION (JP) 2015-10-29 US disclosed
CN-102482520-B Pigment dispersion containing azo pigment and aqueous ink for inkjet recording using the same FUJIFILM CORP 2014-05-14 CN disclosed
US-20120165436-A1 PIGMENT DISPERSION CONTAINING AZO PIGMENT AND AQUEOUS INK FOR INKJET RECORDING USING THE SAME FUJIFILM CORPORATION (JP) 2012-06-28 US disclosed
CN-102482520-A Pigment dispersion containing azo pigment and aqueous ink for inkjet recording using the same FUJIFILM CORP 2012-05-30 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150307467-A1 NOVEL NORBORNENE DERIVATIVE NOS1, CBR1, NOS2 CYP19A1 114/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.